In-vivo Small Animal Fat Content Analyzer QMR21-070H is designed for observe in-vivo small animals. In-vivo Small Animal Fat Content Analyzer QMR21-070H can provide high contrast images, it also has an intuitive user interface. It can be widely used in life sciences for in-vivo study including measuring fat content and fat distribution imaging.
•Magnet Type: Permanent Magnet
•Magnetic Field Intensity: 0.5 T
•No anaesthetize, no execution, save animal cost.
•No preprocessing, finish in 2 min.
•Animal analysis and imaging integration.
In-vivo Small Animal Analyzer QMR21-070H Application:
•small animal's fat content test
Note:If the appearance of the instrument is changed, the technical data of the product shall prevail. The price is subject to the supplier's quotation.
About the company
- Year established
- Business type
- Number of employees
- Bikudo member since
- Jun 2018
NIUMAG Corporation is an international high-tech corporation focusing on development and application spread of low-field NMR (Nuclear Magnetic Resonance), with strong development ability, sophisticated customer service system and internal management system.
NIUMAG Corporation now has three core product lines, multiple invention patents and software copyrights. Independent development and innovation mechanism and perfect product architecture has formed in both core technique and product lines. The NMR imaging system pioneered by NIUMAG Corporation as a technology-mature and performance-steady laboratory analytical instrument has obtained several national certificates, and it has been widely used and unanimously approved in agriculture and food, petroleum prospecting, chemical fiber industry, biomedical, etc.
Through years of successful market operation and extending technology, NIUMAG product line has formed peculiar solutions for low-field NMR technology, providing customer mature, steady and excellent industry and product solutions. We are proud to say NIUMAG Corporation has grown up to the most promising and dynamic enterprise in low-field NMR industry.
In 2015, NIUMAG sold products to Harvard Medical School–Massachusetts General Hospital, which marks the NIUMAG’s products successfully entered the US market and won the reorganization from world’s top scientists.
In 2016, Suzhou NIUMAG Analysis Instruments Corporation had public listed on the National Equities Exchange and Quotations (stock symbol: 836507) which marks NIUMAG has already on its fast developing path. With the boosting of capital operation and the joint effort of every stuff, NIUMAG is blooming.